stella
beta
Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer — Stella
Recruiting
Back to Lung Non-Small Cell Carcinoma trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
United States
Emory University/Winship Cancer Institute, Atlanta, Georgia
View full record on ClinicalTrials.gov